511523 Stock Overview
Veerhealth Care Limited engages in the manufacturing, marketing, and trading of ayurvedic medicines in India.
Price History & Performance
|Historical stock prices|
|Current Share Price||₹12.75|
|52 Week High||₹18.98|
|52 Week Low||₹8.20|
|1 Month Change||5.81%|
|3 Month Change||15.07%|
|1 Year Change||24.76%|
|3 Year Change||61.39%|
|5 Year Change||-2.15%|
|Change since IPO||632.76%|
Recent News & Updates
|511523||IN Pharmaceuticals||IN Market|
Return vs Industry: 511523 exceeded the Indian Pharmaceuticals industry which returned -8.1% over the past year.
Return vs Market: 511523 exceeded the Indian Market which returned 15.1% over the past year.
|511523 Average Weekly Movement||7.4%|
|Pharmaceuticals Industry Average Movement||6.9%|
|Market Average Movement||7.2%|
|10% most volatile stocks in IN Market||10.0%|
|10% least volatile stocks in IN Market||4.7%|
Stable Share Price: 511523 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 511523's weekly volatility (7%) has been stable over the past year.
About the Company
Veerhealth Care Limited engages in the manufacturing, marketing, and trading of ayurvedic medicines in India. The company offers skincare products, such as creams, lip balms, moisturizing lotions, face packs, rosewater, and scrubs; body care products, including bodywash, facewash, handwash, and soaps; hair oils, shampoos, and conditioners; body mist fragrances; pain relief oils, tablets, syrups, and sanitizers; toothpaste; gifting products; and other accessories. It also exports its products.
Veerhealth Care Fundamentals Summary
|511523 fundamental statistics|
Is 511523 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|511523 income statement (TTM)|
|Cost of Revenue||₹69.40m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.072|
|Net Profit Margin||0.47%|
How did 511523 perform over the long term?See historical performance and comparison
Is Veerhealth Care undervalued compared to its fair value and its price relative to the market?
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 511523 (₹12.75) is trading below our estimate of fair value (₹56.33)
Significantly Below Fair Value: 511523 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 511523 is poor value based on its PE Ratio (176.5x) compared to the Indian Pharmaceuticals industry average (22.8x).
PE vs Market: 511523 is poor value based on its PE Ratio (176.5x) compared to the Indian market (20.9x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 511523's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 511523 is good value based on its PB Ratio (0.6x) compared to the IN Pharmaceuticals industry average (2.8x).
How is Veerhealth Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Veerhealth Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Veerhealth Care performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 511523 has high quality earnings.
Growing Profit Margin: 511523 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: 511523's earnings have declined by 8.3% per year over the past 5 years.
Accelerating Growth: 511523 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 511523 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (14.6%).
Return on Equity
High ROE: 511523's Return on Equity (0.4%) is considered low.
How is Veerhealth Care's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 511523's short term assets (₹62.3M) exceed its short term liabilities (₹9.4M).
Long Term Liabilities: 511523's short term assets (₹62.3M) exceed its long term liabilities (₹36.3M).
Debt to Equity History and Analysis
Debt Level: 511523 is debt free.
Reducing Debt: 511523 has no debt compared to 5 years ago when its debt to equity ratio was 6.9%.
Debt Coverage: 511523 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 511523 has no debt, therefore coverage of interest payments is not a concern.
What is Veerhealth Care current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 511523's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 511523's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 511523's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 511523's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 511523 has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Bhavin Shah (40 yo)
Mr. Bhavin Satish Shah serves as Non-Executive Director at Veer Energy & Infrastructure Limited. Mr. Shah has been Managing Director at Veerhealth Care Limited since May 22, 2013 and its Whole Time Directo...
CEO Compensation Analysis
Compensation vs Market: Bhavin's total compensation ($USD12.48K) is below average for companies of similar size in the Indian market ($USD39.20K).
Compensation vs Earnings: Bhavin's compensation has been consistent with company performance over the past year.
Experienced Board: 511523's board of directors are considered experienced (9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Veerhealth Care Limited's employee growth, exchange listings and data sources
- Name: Veerhealth Care Limited
- Ticker: 511523
- Exchange: BSE
- Founded: 1992
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: ₹88.412m
- Shares outstanding: 6.93m
- Website: https://veerhealthcare.net
Number of Employees
- Veerhealth Care Limited
- 629-A, Gazdar House
- 1st Floor
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/07 00:00|
|End of Day Share Price||2022/05/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.